Search Results - "Calhoun, D. A."

Refine Results
  1. 1

    Apparent and true resistant hypertension: definition, prevalence and outcomes by Judd, E, Calhoun, D A

    Published in Journal of human hypertension (01-08-2014)
    “…Resistant hypertension, defined as blood pressure (BP) remaining above goal despite the use of ⩾3 antihypertensive medications at maximally tolerated doses…”
    Get full text
    Journal Article
  2. 2

    Resistant hypertension, obstructive sleep apnoea and aldosterone by Dudenbostel, T, Calhoun, D A

    Published in Journal of human hypertension (01-05-2012)
    “…Obstructive sleep apnoea (OSA) and hypertension commonly coexist. Observational studies indicate that untreated OSA is strongly associated with an increased…”
    Get full text
    Journal Article
  3. 3

    Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report by Gaddam, K, Pimenta, E, Thomas, S J, Cofield, S S, Oparil, S, Harding, S M, Calhoun, D A

    Published in Journal of human hypertension (01-08-2010)
    “…Obstructive sleep apnoea (OSA) and hyperaldosteronism are very common in subjects with resistant hypertension. We hypothesized that aldosterone-mediated…”
    Get full text
    Journal Article
  4. 4

    Efficacy and safety of initial combination therapy with amlodipine valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND study by Flack, J M, Calhoun, D A, Satlin, L, Barbier, M, Hilkert, R, Brunel, P

    Published in Journal of human hypertension (01-07-2009)
    “…The strategy of initiating hypertension treatment with combination versus single-drug therapy was formally tested in a prospective, double-blind,…”
    Get full text
    Journal Article
  5. 5

    Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease by Pisoni, R, Acelajado, M C, Cartmill, F R, Dudenbostel, T, Dell'Italia, L J, Cofield, S S, Oparil, S, Calhoun, D A

    Published in Journal of human hypertension (01-08-2012)
    “…Hypertension is a major risk factor for the development and progression of chronic kidney disease (CKD). Mineralocorticoid receptor antagonists (MRAs) are…”
    Get full text
    Journal Article
  6. 6

    Effect of spironolactone on diastolic function in hypertensive left ventricular hypertrophy by Gupta, A, Schiros, C G, Gaddam, K K, Aban, I, Denney, T S, Lloyd, S G, Oparil, S, Dell'Italia, L J, Calhoun, D A, Gupta, H

    Published in Journal of human hypertension (01-04-2015)
    “…We have previously shown rapid reversal of left ventricular hypertrophy (LVH) with 6 months of spironolactone therapy in patients with resistant hypertension…”
    Get full text
    Journal Article
  7. 7

    24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension by Lacourcière, Y, Crikelair, N, Glazer, R D, Yen, J, Calhoun, D A

    Published in Journal of human hypertension (01-10-2011)
    “…To determine the effectiveness and safety of once-daily combination therapy with amlodipine, valsartan and hydrochlorothiazide for reducing ambulatory blood…”
    Get full text
    Journal Article
  8. 8

    Characteristics of resistant hypertension: ageing, body mass index, hyperaldosteronism, cardiac hypertrophy and vascular stiffness by Martins, L C, Figueiredo, V N, Quinaglia, T, Boer-Martins, L, Yugar-Toledo, J C, Martin, J F V, Demacq, C, Pimenta, E, Calhoun, D A, Moreno, H

    Published in Journal of human hypertension (01-09-2011)
    “…Resistant hypertension (RHTN) includes patients whose blood pressure (BP) is controlled with the use of four or more antihypertensive medications, and is…”
    Get full text
    Journal Article
  9. 9

    Non-dipping pattern relates to endothelial dysfunction in patients with uncontrolled resistant hypertension by Quinaglia, T, Martins, L C, Figueiredo, V N, Santos, R C, Yugar-Toledo, J C, Martin, J F Vilela, Demacq, C, Pimenta, E, Calhoun, D A, Moreno, H

    Published in Journal of human hypertension (01-11-2011)
    “…Resistant hypertension (RHTN) includes both patients whose blood pressure (BP) is uncontrolled on three or more medications (uncontrolled RHTN (UCRH)) and…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Mechanisms responsible for sympathetic activation by cigarette smoking in humans by GRASSI, G, SERAVALLE, G, CALHOUN, D. A, BOLLA, G. B, GIANNATTASIO, C, MARABINI, M, DEL BO, A, MANCIA, G

    Published in Circulation (New York, N.Y.) (01-07-1994)
    “…The pressor and tachycardic effects of cigarette smoking are associated with an increase in plasma catecholamines, suggesting the dependence of these effects…”
    Get full text
    Journal Article
  13. 13

    Maternal and neonatal demographics of macrosomic infants admitted to the neonatal intensive care unit by Tolosa, J N, Calhoun, D A

    Published in Journal of perinatology (01-12-2017)
    “…Objective: The objective of this study is to determine the incidence, significance, associated demographics and impact of macrosomic infants (⩾4 kg) admitted…”
    Get full text
    Journal Article
  14. 14

    Effectiveness of initiating treatment with valsartan hydrochlorothiazide in patients with stage-1 or stage-2 hypertension by Zappe, D H, Palmer, B F, Calhoun, D A, Purkayastha, D, Samuel, R, Jamerson, K A

    Published in Journal of human hypertension (01-07-2010)
    “…This prospective, 6-week, multicenter, double-blind study examined the benefits of initiating treatment with combination valsartan/hydrochlorothiazide (HCTZ)…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Immune-mediated neutropenia in the neonate by Maheshwari, A, Christensen, RD, Calhoun, DA

    Published in Acta Paediatrica (01-09-2002)
    “…Alloimmune neonatal neutropenia, neonatal autoimmune neutropenia and autoimmune neutropenia of infancy have remained nebulous entities with difficulties in…”
    Get full text
    Journal Article
  17. 17

    Enteral administration of hematopoietic growth factors in the neonatal intensive care unit by Calhoun, DA

    Published in Acta Paediatrica (01-09-2002)
    “…By 20 wk of gestation, the human fetal gastrointestinal (GI) tract morphologically resembles that of the term infant, but functional development is limited…”
    Get full text
    Journal Article
  18. 18

    Plasma thrombopoietin concentrations in thrombocytopenic and non‐thrombocytopenic patients in a neonatal intensive care unit by Sola, Martha C., Calhoun, Darlene A., Hutson, Alan D., Christensen, Robert D.

    Published in British journal of haematology (01-01-1999)
    “…Thrombocytopenia is a frequent occurrence in the neonatal intensive care unit (NICU), but the role of thrombopoietin (Tpo) in the pathophysiology is unknown…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Normotensive Blacks Have Heightened Sympathetic Response to Cold Pressor Test by Calhoun, David A, Mutinga, Muthoka L, Collins, Angela S, Wyss, J Michael, Oparil, Suzanne

    Published in Hypertension (Dallas, Tex. 1979) (01-12-1993)
    “…The purpose of this study was to compare sympathetic nerve activity responses to the cold pressor test in black and white normotensive subjects. We recorded…”
    Get full text
    Journal Article